Spirocyclic amides as cannabinoid receptor modulators

Details for Australian Patent Application No. 2003215024 (hide)

Owner Merck & Co., Inc.

Inventors Shah, Shrenik K; Hagmann, William K; Goulet, Mark T; Lin, Linus S; Jewell, James P

Agent Spruson & Ferguson

Pub. Number AU-B-2003215024

PCT Number PCT/US03/08722

PCT Pub. Number WO2003/082190

Priority 60/367,655 26.03.02 US

Filing date 21 March 2003

Wipo publication date 13 October 2003

Acceptance publication date 21 February 2008

International Classifications

C07D 307/24 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/27 (2006.01)

A61K 31/275 (2006.01) - Nitriles

A61K 31/341 (2006.01) - not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

A61K 31/351 (2006.01) - not condensed with another ring

A61K 31/397 (2006.01) - having four-membered rings, e.g. azetidine

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/401 (2006.01) - Proline

A61K 31/4015 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/4402 (2006.01) - only substituted in position 2, e.g. pheniramine, bisacodyl

A61K 31/4406 (2006.01) - only substituted in position 3, e.g. zimeldine

A61K 31/4409 (2006.01) - only substituted in position 4, e.g. isoniazid, iproniazid

A61K 31/4425 (2006.01) - Pyridinium derivatives, e.g. pralidoxime, pyridostigmine

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 31/4545 (2006.01)

A61K 31/5375 (2006.01) - 1,4-Oxazines, e.g. morpholine

A61P 1/10 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/14 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 60/367,655 26.03.02 US

20 November 2003 Application Open to Public Inspection

  Published as AU-B-2003215024

21 February 2008 Application Accepted

  Published as AU-B-2003215024

19 June 2008 Standard Patent Sealed

21 January 2010 Amendment Made

  The nature of the amendment is: Amend patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

20 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003215025-METHOD AND APPARATUS FOR IDENTIFYING MOLECULAR SPECIES ON A CONDUCTIVE SURFACE

2003215023-Method for producing pseudo islets